Literature DB >> 31296945

Can circulating microRNAs solve clinical dilemmas in testicular germ cell malignancy?

Matthew J Murray1,2, Nicholas Coleman3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31296945     DOI: 10.1038/s41585-019-0214-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  4 in total

Review 1.  Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.

Authors:  Adriana Fonseca; João Lobo; Florette K Hazard; Joanna Gell; Peter K Nicholls; Robert S Weiss; Lindsay Klosterkemper; Samuel L Volchenboum; James C Nicholson; A Lindsay Frazier; James F Amatruda; Aditya Bagrodia; Michelle Lockley; Matthew J Murray
Journal:  Br J Cancer       Date:  2022-10-13       Impact factor: 9.075

Review 2.  Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.

Authors:  Kristian Almstrup; João Lobo; Nina Mørup; Gazanfer Belge; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Klaus-Peter Dieckmann
Journal:  Nat Rev Urol       Date:  2020-03-10       Impact factor: 14.432

3.  Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.

Authors:  Matthew J Murray; Thankamma Ajithkumar; Fiona Harris; Rachel M Williams; Ibrahim Jalloh; Justin Cross; Milind Ronghe; Dawn Ward; Cinzia G Scarpini; James C Nicholson; Nicholas Coleman
Journal:  Neurooncol Adv       Date:  2020-04-13

4.  Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data.

Authors:  João Lobo; Ad J M Gillis; Annette van den Berg; Lambert C J Dorssers; Gafanzer Belge; Klaus-Peter Dieckmann; Henk P Roest; Luc J W van der Laan; Jourik Gietema; Robert J Hamilton; Carmen Jerónimo; Rui Henrique; Daniela Salvatori; Leendert H J Looijenga
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.